168 related articles for article (PubMed ID: 22064082)
1. When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
Fuccio C; Musto A; Cambioli S; Castellucci P; Pantaleo MA; Nanni C; Montini GC; Campana D; Tomassetti P; Bellan E; Massaro A; Grassetto G; Rubello D; Fanti S
Clin Nucl Med; 2011 Dec; 36(12):1109-11. PubMed ID: 22064082
[No Abstract] [Full Text] [Related]
2. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
3. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
4. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
[TBL] [Abstract][Full Text] [Related]
5. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Chan M; Schembri GP
Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
[TBL] [Abstract][Full Text] [Related]
6. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
[TBL] [Abstract][Full Text] [Related]
7. A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT.
Taralli S; Treglia G; Perotti G; Graziano P; Cardillo G; Castaldi P; Calcagni ML; Rufini V; Giordano A
Clin Nucl Med; 2012 Apr; 37(4):e91-4. PubMed ID: 22391733
[No Abstract] [Full Text] [Related]
8. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
Jain S; Sharma P; Dhull VS; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):358-9. PubMed ID: 24217543
[TBL] [Abstract][Full Text] [Related]
9. 68Ga DOTATATE PET/CT uptake in spinal lesions and MRI correlation on a patient with neuroendocrine tumor: potential pitfalls.
Klinaki I; Al-Nahhas A; Soneji N; Win Z
Clin Nucl Med; 2013 Dec; 38(12):e449-53. PubMed ID: 23531732
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
11. Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review.
Evangelista L; Ravelli I; Bignotto A; Cecchin D; Zucchetta P
Clin Imaging; 2020 Nov; 67():113-116. PubMed ID: 32559681
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma: Comparison With 18F-FDG.
Derlin T; Sohns JM; Hueper K
Clin Nucl Med; 2017 Apr; 42(4):e210-e211. PubMed ID: 28166150
[TBL] [Abstract][Full Text] [Related]
13. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
14. Rare case of gall bladder neuroendocrine tumor: ¹⁸F-FDG and ⁶⁸Ga-DOTANOC PET/CT findings.
Chakraborty PS; Dhull VS; Karunanithi S; Roy SG; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):316-7. PubMed ID: 25043774
[No Abstract] [Full Text] [Related]
15. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
[TBL] [Abstract][Full Text] [Related]
16. PET/CT with 68Gallium-DOTA-peptides in NET: an overview.
Ambrosini V; Campana D; Tomassetti P; Grassetto G; Rubello D; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e116-9. PubMed ID: 20800401
[TBL] [Abstract][Full Text] [Related]
17. Role of PET/CT in the functional imaging of endocrine pancreatic tumors.
Rufini V; Baum RP; Castaldi P; Treglia G; De Gaetano AM; Carreras C; Kaemmerer D; Hommann M; Hörsch D; Bonomo L; Giordano A
Abdom Imaging; 2012 Dec; 37(6):1004-20. PubMed ID: 22422069
[TBL] [Abstract][Full Text] [Related]
18. Schmorl Nodes Can Cause Increased 68Ga DOTATATE Activity on PET/CT, Mimicking Metastasis in Patients With Neuroendocrine Malignancy.
Papadakis GZ; Millo C; Bagci U; Sadowski SM; Stratakis CA
Clin Nucl Med; 2016 Mar; 41(3):249-50. PubMed ID: 26562580
[TBL] [Abstract][Full Text] [Related]
19. Imaging of multiple brown tumors both in FDG (18F) and 68Ga DOTA-TATE PET/CT studies.
Asa S; Yılmaz S; Kaya R; Sağer S; Halac M; Kabasakal L
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):404-5. PubMed ID: 23849852
[No Abstract] [Full Text] [Related]
20. Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation.
von Falck C; Boerner AR; Galanski M; Knapp WH
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):812. PubMed ID: 17242919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
